Copy number variant in the candidate tumor suppressor gene MTUS1 and familial breast cancer risk

Carcinogenesis

Volumn 28, Issue 7, 2007, Pages 1442-1445

  Frank, Bernd ^a   Bermejo, Justo Lorenzo ^a   Hemminki, Kari ^a,b   Sutter, Christian ^c   Wappenschmidt, Barbara ^d,e   Meindl, Alfons ^f   Kiechle Bahat, Marion ^f   Bugert, Peter ^c   Schmutzler, Rita K ^d,e   Bartram, Claus R ^c   Burwinkel, Barbara ^a  

^a GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^b KAROLINSKA INSTITUTE   (Sweden)

^c UNIVERSITY OF HEIDELBERG   (Germany)

^d UNIVERSITY OF COLOGNE   (Germany)

^e UNIVERSITY HOSPITAL OF COLOGNE   (Germany)

^f TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

MITOCHONDRIAL TUMOR SUPPRESSOR GENE 1; PROTEIN MTUS1; TUMOR SUPPRESSOR PROTEIN; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER PATIENT; CANCER RISK; CASE CONTROL STUDY; CONFIDENCE INTERVAL; CONTROLLED STUDY; FAMILIAL CANCER; FEMALE; GENE DELETION; GENE NUMBER; GENETIC ASSOCIATION; GENETIC VARIABILITY; HIGH RISK PATIENT; HUMAN; INDIVIDUALITY; MAJOR CLINICAL STUDY; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN ANALYSIS; TUMOR SUPPRESSOR GENE;

ADULT; AGED; AGED, 80 AND OVER; ALLELES; BASE SEQUENCE; BREAST NEOPLASMS; CASE-CONTROL STUDIES; EXONS; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MIDDLE AGED; MOLECULAR SEQUENCE DATA; RISK; TUMOR SUPPRESSOR PROTEINS;

EID: 34547730931     PISSN: 01433334     EISSN: 14602180     Source Type: Journal    
DOI: 10.1093/carcin/bgm033     Document Type: Article

References (31)

1. Sebat, J. et al. (2004) Large-scale copy number polymorphism in the human genome. Science, 305, 525-528.
2. Sharp, A.J. et al. (2005) Segmental duplications and copy-number variation in the human genome. Am. J. Hum. Genet., 77, 78-88.
3. Feuk,L. et al. (2006) Structural variation in the human genome. Nat. Rev. Genet., 7, 85-97.
4. Wirtenberger,M. et al. (2006) Identification of frequent chromosome copy-number polymorphisms by use of high-resolution single-nucleotide-polymorphism. arrays. Am. J. Hum. Genet., 78 520-522.
5. Hinds,DA. et al. (2006) Common deletions and SNPs are in linkage dis-equilibrium in the human genome. Nat. Genet., 38, 82-85.
6. Seibold,S. et al. (2003) Identification of a new tumor suppressor gene located at chromosome 8p21.3-22. FASEB J., 17, 1180-1182.
7. Kinjo,T. et al. (2000) Molecular cloning and characterization of two novel genes on chromosome 8p21.3. J. Hum. Genet., 45, 12-17.
8. Pineau,P. et al. (1999) Identification of three distinct regions of allelic deletions on the short arm of chromosome 8 in hepatocellular carcinoma. Oncogene, 18, 3127-3134.
9. Pils,D. et al. (2005) Five genes from chromosomal band 8p22 are significantly down-regulated in ovarian carcinoma: N33 and EFA6R have a potential impact on overall survival. Cancer, 104, 2417-2429.
10. Chaib,H. et al. (2003) Haploinsufficiency and reduced expression of genes localized to the 8p chromosomal region in human prostate tumors. Genes Chromosomes Cancer, 37, 306-313.
11. Wilson,P. et al. (2003) Transfer of chromosome 8 into two breast cancer cell lines: Total exclusion of three regions indicates location of putative in vitro growth suppressor genes. Cancer Genet. Cytogenet., 143, 100-112.
12. Yokota,T. et al. (1999) Localization of a tumor suppressor gene associated with the progression of human breast carcinoma within a 1-cM interval of 8p22-p23.1. Cancer, 85, 447-452.
13. Charafe-Jauffret,E. et al. (2002) Loss of heterozygosity at microsatellite markers from region p1 1-21 of chromosome 8 in microdissected breast tumor but not in peritumond cells. Int. J. Oncol., 21, 989-996.
14. Kerangueven,F. et al. (1997) Genome-wide search for loss of heterozygosity shows extensive genetic diversity of human breast carcinomas. Cancer Res., 57, 5469-5474.
15. Nouet,S. et al. (2004) Trans-inactivation of receptor tyrosine kinases by novel angiotensin II AT2 receptor-interacting protein, ATIP. J. Biol. Chem., 279, 28989-28997.
16. Nouet,S. et al. (2000) Signal transduction from the angiotensin II AT2 receptor. Trends Endocrinol. Metab., 11, 1-6.
17. Di Benedetto,M. et al. (2006) Mutation analysis of the 8p22 candidate tumor suppressor gene ATIP/MTUS1 in hepatocellular carcinoma. Mol. Cell. Endocrinol., 252, 207-215.
18. Deshayes,F. et al. (2005) Angiotensin receptors: A new role in cancer? Trends Endocrinol. Metab., 16, 293-299.
19. Wruck,C.J. et al. (2005) Regulation of transport of the angiotensin AT2 receptor by a novel membrane-associated Golgi protein. Arterioscler Thromb. Vasc. Biol., 25, 57-64.
20. Greco,S. et al. (2002) Activation of angiotensin II type I receptor promotes protein kinase C trandocation and cell proliferation in human cultured breast epithelial cells. J. Endocrinol., 174 205-214.
21. Meindl,A. et al. (2002) Comprehensive analysis of 989 patients with breast or ovarian cancer provides BRCA1 and BRCA2 mutation profiles and frequencies for the German population. Int. J. Cancer, 97 472-480.
22. Frank,B. et al. (2005) The rare ERBB2 variant Ile654Val is associated with an increased familial breast cancer risk. Carcinogenesis, 26, 643-647.
23. Hemminki,K. et al. (2006) Constraints for genetic association studies imposed by attributable fraction and familial risk. Carcinogenesis.
24. Hemminki,K. et al. (2006) The balance between heritable and environmental aetiology of human disease. Nat. Rev. Genet., 7 958-965.
25. Antoniou,A.C. et al. (2003) Polygenic inheritance of breast cancer implications for design of association studies. Genet. Epidemiol., 25, 190-202.
26. Di Benedetto,M. et al. (2006) Structural organization and expression of human MTUS1, a candidate 8p22 tumor suppressor gene encoding a family of angiotensin II AT2 receptor-interacting proteins, ATIP. Gene, 380, 127-136.
27. Macias,M.J. et al. (2002) WW and SH3 domains, two different scaffolds to recognize proline-rich ligands. FEBS Lett., 513 30-37.
28. Reiter,R. et al. (2001) An isoform of the coactivator AEB1 that increases hormone and growth factor sensitivity is overexpressed in break cancer. J. Biol. Chem., 276, 39736-39741.
29. Mercatante,D.R. et al. (2001) Modification of alternative splicing of Bcl-x pre-mRNA in prostate and breast cancer cells. Analysis of apoptosis and cell death. J. Biol. Chem., 276, 16411-16417.
30. Bingle,C.D. et al. (2000) Exon skipping in Mcl- 1 results in a bcl-2 homology domain 3 only gene product that promotes cell death. J. Biol. Chem., 275, 22136-22146.
31. Parl,F.F. (2005) Glutathione S-transferase genotypes and cancer risk. Cancer Lett., 221, 123-129.